Lazard Asset Management LLC Amneal Pharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $63.4 Billion
- Q2 2025
A detailed history of Lazard Asset Management LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 56,433 shares of AMRX stock, worth $638,257. This represents 0.0% of its overall portfolio holdings.
Number of Shares
56,433
Previous 50,790
11.11%
Holding current value
$638,257
Previous $425,000
7.29%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
147MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$199 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$139 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$132 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$128 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$63.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.71B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...